Department of Society and Health, Mahidol University, Nakhon Pathom, Thailand.
College of Health Solutions, Arizona State University, Phoenix, AZ, USA.
J Psychoactive Drugs. 2024 Jan-Mar;56(1):1-7. doi: 10.1080/02791072.2023.2176954. Epub 2023 Feb 9.
From 2018 to 2021, seizures of counterfeit oxycodone pills containing non-pharmaceutical fentanyl or other novel synthetic opioids increased significantly contributing to continuing increases in overdose mortality in Northern America. Evidence suggests that counterfeit pills are distributed through cryptomarkets. This article presents data regarding the availability and characteristics of oxycodone pills advertised on one major cryptomarket between January and March 2022. Collected data were processed using a dedicated Named Entity Recognition algorithm to identify oxycodone listings and categorized them as either counterfeit or pharmaceutical. Frequency of listings, average number of pills advertised, average prices per milligram, number of sales, and geographic indicators of shipment origin and destination were analyzed. In total, 2,665 listings were identified as oxycodone. 48.2% (1,285/2,665) of these listings were categorized as counterfeit oxycodone, advertising a total of 652,699 pills (93,242.7 pills per datapoint) offered at a lower price than pharmaceutical pills. Our data indicate the presence of a large volume of counterfeit oxycodone pills both in retail- and wholesale-level amounts mostly targeting US and Canadian customers. These exploratory findings call for more research to develop epidemiological surveillance systems to track counterfeit pill and other drug availability on the Dark web environment.
从 2018 年到 2021 年,含有非药用芬太尼或其他新型合成阿片类药物的假冒羟考酮药丸的缉获量显著增加,导致北美地区的过量死亡率持续上升。有证据表明,假冒药丸是通过加密货币市场分发的。本文介绍了 2022 年 1 月至 3 月期间一个主要加密货币市场上羟考酮药丸广告的供应和特征的数据。收集的数据使用专用的命名实体识别算法进行处理,以识别羟考酮清单,并将其归类为假冒或药物。分析了清单的出现频率、广告的平均药丸数量、每毫克的平均价格、销售量以及发货的地理指标。总共确定了 2665 个羟考酮清单。其中 48.2%(1285/2665)被归类为假冒羟考酮,总共广告了 652699 片药丸(每个数据点 93242.7 片药丸),价格低于药物药丸。我们的数据表明,无论是零售还是批发数量,都存在大量的假冒羟考酮药丸,主要针对美国和加拿大的客户。这些探索性发现呼吁开展更多研究,以开发流行病学监测系统,以追踪暗网环境中假冒药丸和其他药物的供应情况。